一个GH分泌的垂体瘤的可卡因诱导的脑卒中
Dalia Cuenca1, Latife Salame-Khouri2, Daniela Shveid-Gerson1
1Department of Medicine American British Cowdray Medical Center Mexico City Mexico.
Clinical case reports
|May 13, 2025
概括
这项案例研究报告了一例罕见的壮病缓解的案例,该案例是由于使用可卡因引发的脑垂体脑,随后发生了脑垂体脑. 患者经历了严重的头痛,并被发现处于缓解状态,避免进一步治疗.
科学领域:
- 内分泌学 在内分泌学.
- 神经学 神经学
- 毒理学 毒理学 毒理学
背景情况:
- 巨症是一种由生长激素过量引起的疾病,导致特征性的身体特征.
- 垂体脑梗塞是垂体腺瘤的罕见但严重的并发症,经常出现突然头痛和视觉障碍.
- 众所周知,可卡因使用有各种心血管和神经效应,但它与垂体脑膜梗塞的关联是事.
研究的目的:
- 报告了可卡因诱导的脑垂体中风后第一个被记录的壮症缓解病例.
- 为了突出这个患者不寻常的表现和结果.
- 讨论潜在的机制,链接可卡因使用,垂体脑,和壮症缓解.
主要方法:
- 一个25岁的男性在使用可卡因后出现严重头痛的病例报告.
- 身体检查显示了巨形状的特征.
- 激素特征评估,包括胰岛素类生长因子1 (IGF-1) 的水平.
- 脑下垂体的磁共振成像 (MRI) 来识别病变.
主要成果:
- 患者呈现出与垂体脑梗塞一致的症状,包括异质的,囊性垂体脑损伤与血液含量.
- 激素评估显示IGF-1水平正常,表明壮症的缓解.
- 由于缓解状态,患者不需要药物或手术干预.
结论:
- 可卡因诱导的垂体脑卒中可以,在罕见的情况下,导致壮症的缓解.
- 这一案例凸显了脑下垂体疾病的复杂性和不可预测性.
- 需要进一步的研究,以阐明药物滥用和垂体脑卒中结果之间的关系.
相关概念视频
Hypoglycemia and Glucagon
142
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
142
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
141
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
141
Adrenal Gland Disorders
1.3K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.3K
Drugs Acting on Autonomic Ganglia: Stimulants
1.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.2K
Major Hormones and Their Functions
263
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
263
Adrenergic Agonists: Indirect-Acting Agents
1.4K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.4K


